| Literature DB >> 27909433 |
Dennis Versluis1, Mari Rodriguez de Evgrafov2, Morten O A Sommer2, Detmer Sipkema1, Hauke Smidt1, Mark W J van Passel3.
Abstract
Wide application of antibiotics has contributed to the evolution of multi-drug resistant human pathogens, resulting in poorer treatment outcomes for infections. In the marine environment, seawater samples have been investigated as a resistance reservoir; however, no studies have methodically examined sponges as a reservoir of antibiotic resistance. Sponges could be important in this respect because they often contain diverse microbial communities that have the capacity to produce bioactive metabolites. Here, we applied functional metagenomics to study the presence and diversity of functional resistance genes in the sponges Aplysina aerophoba, Petrosia ficiformis, and Corticium candelabrum. We obtained 37 insert sequences facilitating resistance to D-cycloserine (n = 6), gentamicin (n = 1), amikacin (n = 7), trimethoprim (n = 17), chloramphenicol (n = 1), rifampicin (n = 2) and ampicillin (n = 3). Fifteen of 37 inserts harbored resistance genes that shared <90% amino acid identity with known gene products, whereas on 13 inserts no resistance gene could be identified with high confidence, in which case we predicted resistance to be mainly mediated by antibiotic efflux. One marine-specific ampicillin-resistance-conferring β-lactamase was identified in the genus Pseudovibrio with 41% global amino acid identity to the closest β-lactamase with demonstrated functionality, and subsequently classified into a new family termed PSV. Taken together, our results show that sponge microbiota host diverse and novel resistance genes that may be harnessed by phylogenetically distinct bacteria.Entities:
Keywords: antibiotic resistance; functional metagenomics; microbiota; resistance gene; sponge
Year: 2016 PMID: 27909433 PMCID: PMC5112248 DOI: 10.3389/fmicb.2016.01848
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Resistance profiles of bacterial strains isolated from the sponges .
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 1 | 1 | ||||||||||||||||
| 2 | |||||||||||||||||
| 1 | 1 | ||||||||||||||||
| 1 | |||||||||||||||||
| 1 | |||||||||||||||||
| 2 | 1 | 1 | 1 |
The strains were isolated and tested for antibiotic resistance in a previous study (Versluis et al, under review). We expanded the profile by also testing for resistance to chlortetracycline, D-cycloserine, gentamicin, amikacin and trimethoprim.
We defined three levels of antibiotic resistance: (i) “resistant”; growth of the bacteria was identical to their growth on media with no antibiotics, (ii) “intermediate resistance”; growth of the bacteria was slower than growth on media with no antibiotics, and (iii) “susceptible”; no growth. Dark green, light green and white indicate that the bacterium was respectively “resistant,” “intermediately resistant”, or “susceptible” to the antibiotic in question.
The accession numbers that link to 16S rRNA gene sequences of these strains are shown.
One small-insert library (library I-31) was prepared in E. coli with pooled genomic DNA from these bacteria. Numerical values indicate the number of times a resistance gene obtained from library I–31 (predicted with an E < 1.0E-7 i.e., at high confidence) was assigned to the strain providing resistance to the antibiotic in question.
Small-insert libraries in .
| 31 sponge bacteria (I-31) | 0.8 Gb | 6 | 1 | 4 | 13 | 1 | 2 | 3 |
| 0.2 Gb | 0 | 0 | 1 | 1 | 0 | 0 | 0 | |
| 0.8 Gb | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 1.7 Gb | 0 | 0 | 2 | 3 | 0 | 0 | 0 |
The libraries were screened for resistance to 14 antibiotics. This table shows the number of resistant clones with unique inserts for the different metagenomic libraries.
No clones were obtained that were resistant to chlortetracycline, polymyxin B, erythromycin, ciprofloxacine, cefotaxime, tetracycline, or imipenem.
Figure 1Characterization of the 26 antibiotic resistance genes that were identified with high confidence ( Amino acid identity distribution of the resistance genes that were obtained from the library of 31 sponge bacteria with their best hit (bitscore sorted) in NCBI's database. (B) Amino acid identity distribution of the resistance genes that were obtained from libraries based on DNA from sponge tissue with their best hit (bitscore sorted) in NCBI's database. (C) The mechanisms of action of all 26 resistance genes. (D) The taxonomic assignments of the resistance genes that were obtained from the library of 31 sponge bacteria.
Inserts that confer resistance to amikacin, D-cycloserine or trimethoprim on which no AR gene was identified with high confidence.
| Iso_Ami2 | I-31 | Amikacin | 2..934 | Flagellar motor protein [ | 92.3 | Aminoglycoside 6′-N-acetyltransferase | |
| 1,043..1,687 | Hypothetical protein [ | 57.9 | |||||
| 1,808..2,197 | ATP-dependent Clp protease ATP-binding subunit ClpA [ | 98.5 | |||||
| 2,293..3,741 | MULTISPECIES: copper amine oxidase [ | 99.6 | |||||
| Iso_Ami3 | I-31 | Amikacin | 2..526 | 16S rRNA (guanine(966)-N(2))-methyltransferase RsmD [ | 98.9 | Aminoglycoside methyltransferase | |
| 1,661..2,977 | Transporter [ | 86.1 | |||||
| Iso_Ami4 | I-31 | Amikacin | 1..1,329 | Amino acid transporter [ | 92.7 | Transmembrane export | |
| Env_Ami3 | Pf | Amikacin | 2..73 | n/a | n/a | ||
| 388..1,005 | Non-canonical purine NTP pyrophosphatase [ | 49.1 | Aminoglycoside modification | ||||
| 1,086..1,382 | Radical SAM protein [ | 59.6 | |||||
| Iso_Dcy1 | I-31 | D-cycloserine | 1..543 | GntR family transcriptional regulator [ | 99.5 | ||
| 593..910 | Major facilitator superfamily transporter [ | 94.3 | Antibiotic efflux | ||||
| 903..1,760 | MFS transporter [ | 95.8 | Antibiotic efflux | ||||
| 1,928..2,206 | Barnase inhibitor [ | 15.9 | |||||
| 2,363..2,785 | MULTISPECIES: iron ABC transporter permease [ | 100 | |||||
| Iso_Dcy2 | I-31 | D-cycloserine | 2..199 | N-acetylmuramic acid 6-phosphate etherase [ | 72.7 | ||
| 333..515 | Hypothetical protein [ | 73.7 | |||||
| 618..1,838 | Hypothetical protein [ | 55.6 | Antibiotic efflux | ||||
| 1,955..2,323 | NADPH:quinone oxidoreductase [ | 74.0 | |||||
| Iso_Dcy3 | I-31 | D-cycloserine | 3..1,214 | GntR family transcriptional regulator [ | 100 | ||
| 1,365..1,586 | EamA-like transporter family, partial [uncultured bacterium] | 82.2 | Antibiotic efflux | ||||
| 1,637..2,284 | MULTISPECIES: multidrug transporter [ | 100 | |||||
| Iso_Dcy4 | I-31 | D-cycloserine | 437..847 | Transporter [ | 93.4 | Antibiotic efflux | |
| 916..1,596 | Transporter [ | 99.5 | Antibiotic efflux | ||||
| 2,031..3,158 | MFS transporter [ | 99.7 | Antibiotic efflux | ||||
| Iso_Dcy5 | I-31 | D-cycloserine | 15..893 | Transporter [ | 99.3 | Antibiotic efflux | |
| 944.1,216 | Succinate dehydrogenase [ | 98.9 | |||||
| 1,203..1,946 | Succinate dehydrogenase [ | 91.9 | |||||
| Iso_Dcy6 | I-31 | D-cycloserine | 1..90 | MULTISPECIES: hypothetical protein [ | 100 | ||
| 95..259 | MULTISPECIES: hypothetical protein [ | 69.9 | |||||
| 409..924 | RTX toxin [ | 70.9 | |||||
| 926..1,576 | RTX toxin [ | 78.7 | |||||
| 1,752..2,105 | Hypothetical protein RHECNPAF_930033 [ | 28.2 | |||||
| 2,102..2,362 | Membrane protein [ | 100 | |||||
| 2,467..3,309 | Putative benzoate transporter [ | 99.6 | Antibiotic efflux | ||||
| Iso_Trim13 | I-31 | Trimethoprim | 3..176 | Sodium:proton exchanger [ | 87.7 | ||
| 246..977 | Short-chain dehydrogenase [ | 84.9 | Oxidoreductase | ||||
| 1,268..3,073 | Excinuclease ABC subunit C [ | 93.3 | |||||
| 3,143..3,685 | Membrane protein [ | 74.4 | |||||
| 3,986..4,492 | Hypothetical protein [ | 91.1 | |||||
| Iso_Trim14 | I-31 | Trimethoprim | 3..440 | Nitrous-oxide reductase [ | 83.5 | Oxidoreductase | |
| 379..828 | Nitrous-oxide reductase [ | 85.1 | Oxidoreductase | ||||
| 800..1,279 | Nitrous-oxide reductase [ | 83.2 | Oxidoreductase | ||||
| 1,858..2,130 | Membrane protein [ | 80.2 | |||||
| 2,096..2,410 | Hypothetical protein [ | 77.8 | |||||
| Env_Trim4 | Aa | Trimethoprim | 3..521 | Td thymidylate synthetase | 80.8 | Thymidylate synthetase | |
| 586..882 | Hypothetical protein SSSM7_321 [ | 75.3 | |||||
| 884..1,273 | P-starvation inducible protein [uncultured Mediterranean phage uvMED] | 81.5 |
We defined a resistance gene to be identified with high confidence if it was detected at an E-value of <1E-7 by either BLASTp or BLASTn against the CARD database, or by employing the pHMMs of the Resfams database. However, on these inserts no resistance genes were identified with high confidence. Therefore, in order to predict the presence of resistance genes, the results from the queries against the CARD and Resfams database were supplemented with protein domain and protein family predications by InterProScan. Based on the combined results, we predicted which genes on these inserts may be responsible for the resistance phenotype. The column “predicted resistance function” contains information about the mechanism of action of the proteins that we predicted to be responsible for the resistance phenotype.
Figure 2Maximum Likelihood Tree based on protein sequences of: the novel ß-lactamase (. In this figure, only the proteins in green and the novel ß-lactamase (blaPSV-1) have demonstrated functionality. The tree was constructed in MEGA using 1000 iterations of bootstrapping. Bootstrap values <50 are not shown. The horizontal bar indicates the number of substitutions per site.